AU5655696A - Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders - Google Patents

Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders

Info

Publication number
AU5655696A
AU5655696A AU56556/96A AU5655696A AU5655696A AU 5655696 A AU5655696 A AU 5655696A AU 56556/96 A AU56556/96 A AU 56556/96A AU 5655696 A AU5655696 A AU 5655696A AU 5655696 A AU5655696 A AU 5655696A
Authority
AU
Australia
Prior art keywords
ysteine
carboc
erdosteine
expectorant
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56556/96A
Inventor
Given Not
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adcock Ingram Ltd
Original Assignee
Adcock Ingram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd filed Critical Adcock Ingram Ltd
Publication of AU5655696A publication Critical patent/AU5655696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56556/96A 1995-05-10 1996-05-09 Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders Abandoned AU5655696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA953778 1995-05-10
ZA95/3778 1995-05-10
PCT/GB1996/001107 WO1996035452A1 (en) 1995-05-10 1996-05-09 Pharmaceutical composition containing acetylcysteine, carbocysteine or erdosteine in combination with a beta 2 agonist and an expectorant for the treatment of respiratory tract disorders

Publications (1)

Publication Number Publication Date
AU5655696A true AU5655696A (en) 1996-11-29

Family

ID=25585074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56556/96A Abandoned AU5655696A (en) 1995-05-10 1996-05-09 Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders

Country Status (3)

Country Link
AU (1) AU5655696A (en)
WO (1) WO1996035452A1 (en)
ZA (1) ZA963590B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311907B1 (en) * 1999-04-06 2002-03-20 Zambon Spa DEGLUTABLE TABLETS WITH HIGH CONTENT OF N-ACETYLCISTEIN.
AU2003205974A1 (en) * 2002-02-13 2003-09-04 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine
US20070071689A1 (en) 2003-08-06 2007-03-29 Galephar M/F Advantageous combination for inhalation of nacystelyn and bronchodilators
CN1303065C (en) * 2004-05-20 2007-03-07 江苏豪森药业股份有限公司 Ambroxol cysteine analogs and their preparation process and use thereof
WO2007035879A2 (en) * 2005-09-20 2007-03-29 Galleon Pharmaceuticals Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm
EP1857106A1 (en) * 2006-05-16 2007-11-21 Edmond Pharma S.R.L. Combinations of erdosteine and beta-2 agonists for treating COPD
JP2010505844A (en) * 2006-10-03 2010-02-25 ガレオン・フアーマシユーチカルズ・インコーポレーテツド S-nitrosothiol compounds and related derivatives
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US20120252824A1 (en) * 2009-06-16 2012-10-04 John Brew Drug Combinations and Uses in Treating a Coughing Condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
WO2011030163A1 (en) * 2009-09-12 2011-03-17 Reckitt Benckiser Llc Use of guaifenesin for inhibiting mucin secretion
WO2011142677A1 (en) * 2010-05-11 2011-11-17 Breathe Easy Ltd Methods and compositions for the treatment of lung disorders
TR201723198A2 (en) * 2017-12-30 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Compositions containing Erdosteine and ascorbic acid.
CN113018444A (en) * 2020-01-09 2021-06-25 海南斯达制药有限公司 Pharmaceutical composition for treating respiratory system diseases and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0530311A1 (en) * 1990-05-21 1993-03-10 Norwich-Eaton Pharmaceuticals, Inc. The use of phenylpropanolamine as a mucus secretagogue in the upper airways
ZA921848B (en) * 1991-05-10 1992-11-25 South African Druggists Ltd Pharmaceutical composition
DK0521388T3 (en) * 1991-07-01 1995-09-11 Gergely Gerhard Process for the preparation of a pharmaceutical composition having at least two different active substances and the use of such a preparation
ZA935931B (en) * 1992-08-18 1994-03-07 South African Druggists Ltd Pharmaceutical composition
ZA94155B (en) * 1992-11-06 1995-07-11 Adcock Ingram Pharma Pharmaceutical composition
BE1007926A3 (en) * 1994-01-31 1995-11-21 Zambon Int Pharma Pharmaceutical composition containing n-acetyl-cysteine.

Also Published As

Publication number Publication date
WO1996035452A1 (en) 1996-11-14
ZA963590B (en) 1996-11-19

Similar Documents

Publication Publication Date Title
EP0745401A3 (en) Inhaler type medicine administering device
AU3204995A (en) Closed drug delivery system
PL322771A1 (en) Salmeterol inhaler with dosis metering feature
AU1850897A (en) Powdered medication inhaler
GB2303064B (en) Medicament for nasal administration
AU6379294A (en) Nasal pharmaceutical composition containing a progestational agent
AU5676596A (en) Oral insulin delivery
AU2827095A (en) Controlled release oral drug delivery system
AU4373596A (en) Metered dose medication adaptor with improved incentive spirometer
AU2873095A (en) Single patient dose medicament dispenser with applicator
DE69530792D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PROLIPOSOME POWDER FOR INHALATION
ZA917528B (en) Nasal pharmaceutical composition.
AU677472B2 (en) Medicine injection device
EP0768094A3 (en) Powder inhalation medication
CA2166483A1 (en) New Pharmaceutical Formulation
AU4050195A (en) Soft gelatin pharmaceutical dosage form
AU5655696A (en) Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders
GB9314598D0 (en) Medicament inhalers
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
AU5993590A (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine and trihydroxy methylamino methane
GB9418064D0 (en) Medicament administration inhaler
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
AU6428994A (en) Formulation for nasal insulin delivery
AU3144993A (en) Fluorophore-assisted therapeutic drug monitoring
AU1740292A (en) Triphenylethylene derivative and pharmaceutical preparation containing the same